Navigation Links
NASP Announces Jim Smeeding, RPh, MBA, as Executive Director
Date:4/10/2013

TAMPA, Fla., April 10, 2013 /PRNewswire-iReach/ -- The National Association of Specialty Pharmacy™ (NASP™) announced the appointment of James E.  Smeeding, RPh, MBA, as the association's first Executive Director. The announcement was made during the NASP Inaugural Specialty Pharmacy Conference, which drew more than 500 participants representing all specialty pharmacy stakeholders. 

"Specialty pharmacy is the fastest growing segment in pharmacy, and we need a strong leader to support NASP's commitment of creating a strong, unified voice for all stakeholders," Gary M. Cohen , BSPharm, RPh, NASP CEO and Co-Founder, said.  "Jim is that leader. He is an experienced, skilled leader who is committed to our core values of improving patient outcomes and fostering a strong environment of collaboration."  

Smeeding, who holds a pharmacy degree from the University of Buffalo and a Masters in Business Administration from the University of Texas, is a well-recognized and widely published leader in the pharmacy industry. He has experience in a variety of areas including hospital pharmacy, clinical services design, home infusion therapy, managed care services and disease management.  Smeeding is the founder of the Center for Pharmacoeconomic Studies at the University of Texas, College of Pharmacy, where he has focused his research on pharmacoeconomics, systems integration and managed care.

"The NASP Board members unanimously felt Jim's previous track record of collaborative and inclusionary leadership in diverse industry roles over the years solidified our belief that he is the right individual to drive the mission of our organization," Burt Zweigenhaft , member of the NASP Board of Directors, said.

During his 40-year career, Smeeding has been instrumental in the development of companies servicing the pharmaceutical industry including the following:

  • The TPG National Payor Roundtable - an educational company that brings product and service offerings to managed care decision makers. 
  • The Jestarx Group - a data and educational resource company that works with pharmaceutical manufacturers in the analysis and presentation of pharmacoeconomic and health outcomes data.
  • Digital Health Dialog a patented patient engagement company utilizing mobile-phone tools that lets users deliver instant, personally targeted messages to patients at more convenient points in their therapy.
  • Project Rx - a service company that works with hospital pharmacies to assess, evaluate and improve quality, safety and efficiency of service delivery.
  • Edjudicate - a private consultancy group that focuses on unique needs of pharmaceutical oriented customers. 

Smeeding's private clients constitute the spectrum of pharmaceutical companies, medical device companies, diagnostic testing and all classes of pharmacy affairs – hospital, retail, chain, managed care, academic and research.  His broad expertise in professional affairs has allowed his clients to understand, approach and impact medical and pharmacy affairs from product selection through to the value proposition as well as professional communications, patient communications and safety.  Jim is widely known for his broad interests and his ability to moderate a program to bring out cogent learning points and make the educational program applicable to practice.

In organizational affairs, Jim held multiple leadership positions within the American Society of Health System Pharmacists (ASHP) and was a founder and president of the International Society of Pharmacoeconmics and Outcomes Research (ISPOR).  His organizational experience and relationships throughout all of pharmacy will allow NASP to forge the collaborative relationships identified within its mission and goals.

"I look forward to the challenge of building partnerships and strengthening collaboration across all channels and practice settings," Smeeding said. "NASP has already made a strong impact and I am honored to work with the Board of Directors to advance our mission and goals.

NASP, founded in 2012, represents specialty pharmacy professionals in all practice settings and highlights the unique value its members bring to patients and the healthcare system. Specialty pharmacy is the fastest growing segment in the industry today and NASP provides valuable benefits to members by creating a strong, unified voice for all stakeholders.

Source: National Association of Specialty Pharmacy (www.nasprx.org)

Media Contact: Gary Cohen , gcohen@nasprx.org

Media Contact: Gary Cohen National Association of Specialty Pharmacy, 813-926-5000, gcohen@nasprx.org

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE National Association of Specialty Pharmacy
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Andain Inc. Announces Successful 510K Tests of its Breakthrough Miniature Disposable Insulin Pump
2. Omeros Announces that GPR17 Antagonists Improve Function in Model of Multiple Sclerosis
3. CryoLife Announces Release Date and Teleconference Call Details for 2013 First Quarter Financial Results
4. Zosano Pharma, Inc. Announces Key Strategic Hire
5. Ingenuity Systems Announces Awardees of Grant Program
6. BD Announces Live Webcast Of Second Fiscal Quarter Earnings Conference Call
7. Pharmacyclics Announces Third Breakthrough Therapy Designation for Ibrutinib from the U.S. Food and Drug Administration
8. scPharmaceuticals LLC Announces Strategic Partnership with Sensile Medical to Develop Novel Heart Failure Treatment Aimed to Reduce Readmission Rates
9. Hanger, Inc. Announces First Quarter 2013 Earnings Release And Conference Call
10. Sigma-Aldrich Announces Q1 2013 Earnings Conference Call
11. Uroplasty Announces CEO Resignation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... LightIntegra Technology Inc. today announced that its ... President and Chief Executive Officer effective March 13, 2017. ... Directors of LightIntegra. Paul Geyer will continue ... "This is the perfect time for Bill ... We,ve selected a very strong leader at a time ...
(Date:3/27/2017)... 2017  Sanderling Ventures, portfolio company, Torax Medical, ... of Johnson & Johnson. Torax manufactures and markets the ... gastro-esophageal reflux disease (GERD). The LINK device is ... the procedure is currently available in the U.S. ... was founded by Sanderling Ventures, Mayo Medical Ventures ...
(Date:3/27/2017)... March 27, 2017 FinancialBuzz.com News Commentary  ... Based on New Frontier ... states where cannabis is legal will generate $655 million in taxes ... from cannabis specific taxes, such as Washington State,s ... be earned from state sales taxes that are applied on all ...
Breaking Medicine Technology:
(Date:3/28/2017)... Wallingford, CT (PRWEB) , ... March 28, 2017 ... ... hemostatic devices, announces today that the University of Pittsburgh Medical Center (UPMC) will ... Central and Western Pennsylvania. , The program, developed in association with efforts by ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... Usually, the ... the daily wardrobe. However, for those self-conscious about a double chin, this means more ... the ideal solution. , “For most people, a double chin is undesirable,” Dr. ...
(Date:3/28/2017)... ... March 28, 2017 , ... Calibration, ... to ensuring high-quality results and maintaining GMP and USP compliance. In a new ... accordance with GMP requirements " these requirements are explained. The challenge is ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... in Wethersfield, Conn., has relocated its corporate headquarters to a new, more expansive ... , In October 2016, Qualidigm purchased a distressed office building in Wethersfield, ...
(Date:3/28/2017)... ... March 28, 2017 , ... With less than 10,000 dermatologists in the United ... can be limited while the desire to conquer breakouts and eliminate skincare stress is ... every customer online, today released its inaugural survey on the State of Acne in ...
Breaking Medicine News(10 mins):